InvestorsHub Logo
Followers 91
Posts 1956
Boards Moderated 0
Alias Born 07/31/2013

Re: RealGenius post# 3

Saturday, 03/29/2014 12:53:32 PM

Saturday, March 29, 2014 12:53:32 PM

Post# of 47
Relevant History
Partnerships, Licensing, Mergers, ...

In May 2013, Ignyta Operating acquired Actagene Oncology, Inc. (Actagene) by way of Actagene’s merger with and into Ignyta Operating on May 20, 2013. All consideration paid by Ignyta Operating in connection with its acquisition of Actagene was paid with shares of its common stock, totaling an aggregate of 1,583,336 shares.

On November 6, 2013, pursuant to the terms of a license agreement between Ignyta Operating and Nerviano Medical Sciences S.r.l (NMS), Ignyta issued to NMS a warrant to acquire up to 16,667 shares of its common stock at an exercise price of $6.00 per share.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.